20 results
8-K
EX-99.2
HOWL
Werewolf Therapeutics Inc
8 Jan 24
Werewolf Therapeutics Provides Business Update and Highlights 2024 Strategic Outlook
8:08am
Carcinoma 2 (12.5%) 3 5 (31.2%) RACE, n (%) Black/African- 1 ( 6.2%) Cutaneous SCC 1 (6.3%) American ≥4 5 (31.2%) White 13 (81.2%) Unknown 2 (12.5
8-K
EX-99.2
gytle1gqker8vwij
3 Nov 23
Regulation FD Disclosure
7:05am
DEF 14A
z5g9j6lf3tf9h04mghwy
22 Apr 22
Definitive proxy
4:01pm
10-K
5pagnh
24 Mar 22
Annual report
7:08am
10-Q
vczbqmbwh946x
10 Jun 21
Quarterly report
7:03am
424B4
alu zkc26ab3avo
30 Apr 21
Prospectus supplement with pricing info
5:30pm
S-1/A
2t1xymy1inw0b
26 Apr 21
IPO registration (amended)
6:06am
S-1
2fxqebxfe0yz
8 Apr 21
IPO registration
5:03pm
- Prev
- 1
- Next